MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
91 hedge funds and large institutions have $149M invested in Melinta Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
22% less call options, than puts
Call options by funds: $371K | Put options by funds: $476K
39% less capital invested
Capital invested by funds: $246M → $149M (-$97M)
Holders
91
Holding in Top 10
2
Calls
$371K
Puts
$476K
Top Buyers
| 1 | +$7.53M | |
| 2 | +$3.03M | |
| 3 | +$2.5M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.64M |
| 5 |
First Manhattan
New York
|
+$1.46M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$6.65M | |
| 3 | -$2.51M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.89M |
| 5 |
Millennium Management
New York
|
-$1.61M |